Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide epidemic of the lethal respiratory coronavirus disease (COVID-19), necessitating urgent development of specific and effective therapeutic tools. Among several therapeutic targets of coronaviruses, the spike...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Zhou, Junhu, Wang, Qixue, Wang, Yunfei, Kang, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738867/
https://www.ncbi.nlm.nih.gov/pubmed/33391497
http://dx.doi.org/10.7150/thno.51479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738867/
https://www.ncbi.nlm.nih.gov/pubmed/33391497
http://dx.doi.org/10.7150/thno.51479

Ejemplares similares